ANXA2 and MALT lymphoma: For instance, a study by Cui et al., found ANXA2 to be overexpressed in the salivary glands of patients with primary Sjögren's disease/mucosal-associated lymphoid tissue (MALT) lymphoma, suggesting that ANXA2 possibly contributes to the pathophysiology of Sjögren's disease, and could represent a potential biomarker of disease progression and lymphoproliferation in patients with the disease.48